Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov 9;8(5):848-53.
doi: 10.5114/aoms.2012.31384. Epub 2012 Oct 30.

Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumours

Aleksandra Mielczarek-Palacz  1 , Zdzisława Kondera-Anasz, Justyna Sikora
Affiliations

Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumours

Aleksandra Mielczarek-Palacz et al. Arch Med Sci. .

Abstract

Introduction: Tumour necrosis factor (TNF) and its soluble receptors type 1 (sTNF-R1) and type 2 (sTNF-R2) have been suggested as key mediators between apoptosis and cancer cell progression. The aim was to examine concentrations of the parameters in the serum of women with ovarian tumour and in the fluid from ovarian cysts of women with serous cystadenoma.

Material and methods: The study included 125 women with ovarian tumours. As a control, sera were obtained from 70 healthy female volunteers. Concentrations of TNF, sTNF-R1 and sTNF-R2 were measured by enzyme-linked immunosorbent assay (ELISA).

Results: Significant increases of TNF, sTNF-R1 and sTNF-R2 were found in the serum of women with ovarian tumour in comparison to the control (p < 0.0001). The highest levels of all studied parameters were observed in women with ovarian cancer. In the ovarian cyst fluid the concentrations of the evaluated parameters increased significantly as compared to the serum (p < 0.0001).

Conclusions: Our data showed changes in regulatory mechanisms of apoptosis in women with ovarian tumours which are associated with increased concentrations of all studied factors. Serum estimated TNF and especially sTNF-R may be used as complementary diagnostic markers in patients with ovarian tumours.

Keywords: ovarian tumours; soluble receptor of tumour necrosis factor; tumour necrosis factor.

PubMed Disclaimer

References

    1. Kwong J, Chan FL, Wong KK, et al. Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cells. Neoplasia. 2009;11:529–41. - PMC - PubMed
    1. Fulda S. Cell death in hematological tumors. Apoptosis. 2009;14:409–23. - PubMed
    1. Wang X, Lin Y. Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin. 2008;29:1275–88. - PMC - PubMed
    1. So T, Lee SW, Croft M. Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity. Int J Hematol. 2006;83:1–11. - PubMed
    1. Ihnatko R, Kubes M. TNF signaling: early events and phosphorylation. Gen Physiol Biophys. 2007;26:159–67. - PubMed